FARMINGTON, Conn., March 3, 2020 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon" or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the fourth quarter and full year ended December 31, 2019.

Fourth Quarter 2019 Highlights

• Net investment income grew to $6.5 million, or $0.43 per share, compared to $4.0 million, or $0.34 per share for the prior-year period
• Total investment portfolio of $319.6 million as of December 31, 2019
• Net asset value of $184.1 million, or $11.83 per share, as of December 31, 2019
• Achieved annualized portfolio yield on debt investments of 17.6% for the quarter
• Funded seven loans totaling $65.0 million during the quarter
• Experienced liquidity events from five portfolio companies
• Raised total net proceeds of approximately $13.8 million with "at-the-market" ("ATM") offering program
• Cash of $16.3 million and credit facility capacity of $108.0 million as of December 31, 2019
• Held portfolio of warrant and equity positions in 75 companies as of December 31, 2019
• Increased undistributed spillover income to $0.42 per share as of December 31, 2019
• Subsequent to quarter end, declared distributions of $0.10 per share payable in April, May and June 2020 and special distribution of $0.05 per share payable in April 2020

Full Year 2019 Highlights

• Net investment income grew to $20.5 million, or $1.52 per share for 2019, compared to $13.9 million, or $1.20 per share, for the prior year
• Achieved portfolio yield on debt investments of 16.7% for 2019
• Funded 27 loans totaling $206.8 million; experienced liquidity events from 19 portfolio companies

"Our excellent fourth quarter performance capped off a great year for Horizon," said Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer of Horizon. "Net investment income of $0.43 per share significantly exceeded our distribution level, while we increased our NAV.  We originated seven new loans for $65 million, growing our portfolio for the seventh consecutive quarter, and generated an annualized debt portfolio yield of 17.6%, which, again, showed the success of our predictive pricing strategy.  We also maintained strong credit quality through our prudent and disciplined underwriting approach.  As a result of our very successful 2019, we are proud to be able to reward our shareholders and their ongoing support with a special distribution of $0.05 per share, in addition to our regular monthly distributions."

"Along with our exceptional results, we utilized our 'at-the-market' program during the quarter and issued an additional $14 million of common stock at a premium to NAV," added Mr. Pomeroy.  "As we look ahead, we continue to see considerable opportunities and strong market demand in the overall venture debt loan market.  With our capital structure significantly enhanced, we are well-capitalized and we believe we are well-positioned to further grow our venture debt portfolio in 2020, while delivering regular monthly distributions and long-term value to our shareholders."

Fourth Quarter 2019 Operating Results

Total investment income for the quarter ended December 31, 2019 grew 47% to $13.0 million, compared to $8.8 million for the quarter ended December 31, 2018. The year-over-year improvement in total investment income is primarily due to growth in interest income on investments resulting from an increase in the average size of the debt investment portfolio, and a higher average prepayment fee rate earned. 

The Company's dollar-weighted annualized yield on average debt investments for the quarter ended December 31, 2019 and 2018 was 17.6% and 16.7%, respectively.  The Company calculates the dollar-weighted annualized yield on average debt investments for any period measured as (1) total investment income (excluding dividend income) during the period divided by (2) the average of the fair value of debt investments outstanding on (a) the last day of the calendar month immediately preceding the first day of the period and (b) the last day of each calendar month during the period. The dollar-weighted annualized yield on average debt investments is higher than what investors will realize because it does not reflect expenses or any sales load paid by investors.

Net expenses for the quarter ended December 31, 2019 were $6.3 million, compared to $4.8 million for the quarter ended December 31, 2018.  The increase was primarily due to $0.4 million of additional interest expense, $0.6 million of higher net performance-based incentive fees and $0.3 million in additional base management fees.

Net investment income for the quarter ended December 31, 2019 was $6.5 million, or $0.43 per share, compared to $4.0 million, or $0.34 per share, for the quarter ended December 31, 2018.

For the quarter ended December 31, 2019, net realized loss on investments was $0.3 million, or $0.02 per share, compared to a net realized gain on investments of $0.9 million, or $0.08 per share, for the quarter ended December 31, 2018.

For the quarter ended December 31, 2019, net unrealized appreciation on investments was $0.6 million, or $0.04 per share, compared to net unrealized depreciation on investments of $1.6 million, or $0.14 per share, for the prior-year period.

Full Year 2019 Operating Results

Total investment income for the year ended December 31, 2019 was $43.1 million, an increase of 39% compared to $31.1 million for the year ended December 31, 2018.

Horizon's dollar-weighted annualized yield on average debt investments for the year ended December 31, 2019 and 2018 was 16.7% and 15.3%, respectively.

For the full year ended December 31, 2019, net investment income was $20.5 million, or $1.52 per share, compared to net investment income of $13.9 million, or $1.20 per share, in the prior year.

For the full year ended December 31, 2019, net realized loss on investments was $4.2 million, or $0.31 per share, compared to net realized gain on investments of $0.6 million, or $0.06 per share, for the full year ended December 31, 2018.

For the full year ended December 31, 2019, net unrealized appreciation on investments was $3.2 million, or $0.24 per share, compared to net unrealized depreciation on investments of $1.5 million, or $0.13 per share, for the full year ended December 31, 2018.

Portfolio Summary and Investment Activity

As of December 31, 2019, the Company's debt portfolio consisted of 35 secured loans with an aggregate fair value of $288.4 million. In addition, the Company's total warrant, equity and other investments in 76 portfolio companies had an aggregate fair value of $14.5 million, and the Company's 50% equity interest in its joint venture had a fair value of $16.7 million as of December 31, 2019.  Total portfolio investment activity for the three months and full year ended December 31, 2019 and 2018 was as follows:

Net Asset Value

At December 31, 2019, the Company's net assets were $184.1 million, or $11.83 per share, compared to $134.3 million, or $11.64 per share, as of December 31, 2018.

For the quarter ended December 31, 2019, net increase in net assets resulting from operations was $6.7 million, or $0.45 per share, compared to $3.2 million, or $0.28 per share, for the quarter ended December 31, 2018.

Portfolio Asset Quality

The following table shows the classification of Horizon's loan portfolio at fair value by internal credit rating as of December 31, 2019 and 2018:

As of December 31, 2019 and 2018, Horizon's loan portfolio had a weighted average credit rating of 3.1, with 4 being the highest credit quality rating and 3 being the rating for a standard level of risk. A rating of 2 represents an increased level of risk and, while no loss is currently anticipated for a 2-rated loan, there is potential for future loss of principal. A rating of 1 represents deteriorating credit quality and high degree of risk of loss of principal. As of December 31, 2019, there were two debt investments with an internal credit rating of 1, with a cost of $5.7 million and a fair value of $2.0 million.  As of December 31, 2018, there were no debt investments with an internal credit rating of 1.

Liquidity Events

During the quarter ended December 31, 2019, Horizon experienced liquidity events from five portfolio companies. Liquidity events for Horizon may consist of the sale of warrants or equity in portfolio companies, loan prepayments, sale of owned assets or receipt of success fees.

In October, Horizon received proceeds of $1.7 million upon the exercise and sale of its warrants in Verity Solutions Group, Inc.

In December, Intelepeer Holdings, Inc. ("Intelepeer") prepaid the outstanding principal balance of $10.8 million on its venture loan, plus interest, end-of-term payment and prepayment fee. Horizon continues to hold warrants in Intelepeer.

In December, CSA Medical, Inc. ("CSA Medical") prepaid its outstanding principal balance of $11.5 million on its venture loan, plus interest, end-of-term payment and prepayment fee. Horizon continues to hold warrants in CSA Medical.

In December, Recondo Technology, Inc. ("Recondo") closed a sale transaction from which Horizon received proceeds of $0.3 million in connection with the termination of Horizon's warrants in Recondo.

In December, Horizon received proceeds of $0.2 million in connection with the sale of its license agreement with Triple Double Holdings, LLC.

Liquidity and Capital Resources

As of December 31, 2019, the Company had $40.5 million in available liquidity, consisting of $16.3 million in cash and money market funds, and $24.2 million in funds available under existing credit facility commitments.

As of December 31, 2019, there was $17.0 million in outstanding principal balance under the $125.0 million revolving credit facility ("Key Facility").  The Key Facility allows for an increase in the total loan commitment up to an aggregate commitment of $150.0 million. There can be no assurance that any additional lenders will make any commitments under the Key Facility.

Horizon Funding Trust 2019-1, a wholly-owned subsidiary of Horizon, previously issued $100.0 million of Asset-Backed Notes (the "Notes") rated A+(sf) by Morningstar Credit Ratings, LLC, and backed by $160.0 million of secured loans originated by Horizon.  The Notes bear interest at a fixed interest rate of 4.21% per annum and have a stated maturity date of September 15, 2027.   As of December 31, 2019, the Notes had an outstanding principal balance of $100.0 million.

During the three months ended December 31, 2019, the Company sold approximately 1.1 million shares of common stock under its previously established ATM sales agreement with Goldman Sachs & Co. LLC and B. Riley FBR, Inc. For the same period, the Company received total accumulated net proceeds of approximately $13.8 million, including $0.4 million of offering expenses, from these sales.

As of December 31, 2019, the Company's debt to equity leverage ratio was 84%, within the Company's 80-120% targeted leverage range.  The asset coverage ratio for borrowed amounts was 219%.

Stock Repurchase Program

On April 26, 2019, the Company's board of directors extended the Company's previously authorized stock repurchase program until the earlier of June 30, 2020 or the repurchase of $5.0 million of the Company's common stock. During the quarter ended December 31, 2019, the Company did not repurchase any shares of its common stock. From the inception of the stock repurchase program through December 31, 2019, the Company has repurchased 167,465 shares of its common stock at an average price of $11.22 on the open market at a total cost of $1.9 million.

Recent Developments

Subsequent to December 31, 2019, and as of March 3, 2020, Horizon sold approximately 1.2 million shares of common stock for total accumulated net proceeds of approximately $15.1 million, net of offering expenses, under its ATM program. As of March 3, 2020, shares representing approximately $10.0 million of its common stock remain available for issuance and sale under its ATM program.

In January, Horizon received proceeds of $2.3 million in connection with the termination of its warrants in Sys-Tech Solutions, Inc. ("Sys-Tech") upon Sys-Tech's sale to Dover Fluids, Inc.

In February, Horizon received proceeds of $0.4 million in connection with the sale of its equity investment in Revance Therapeutics, Inc.

In February, Bridge2 Solutions, LLC ("Bridge2") prepaid its outstanding principal balance of $14.5 million on its venture loan, plus interest and end-of-term payment. Also in February, Horizon received proceeds of $2.9 million in connection with the termination of its warrants in Bridge2 upon Bridge2's sale to Intercontinental Exchange, Inc.

In February, Horizon funded a $20.0 million loan to a new portfolio company, Castle Creek Biosciences, Inc., a clinical stage biopharmaceutical company developing therapies for patients with rare and debilitating dermatological conditions.

In February, Horizon funded a $4.0 million loan to a former portfolio company, CSA Medical, Inc., a developer of novel, patent-protected cryotherapy medical devices.

In February, Horizon funded a $1.1 million loan to an existing portfolio company, Betabrand Corporation, a crowdfunded online clothing community that designs, manufactures, and consistently releases new products.

Monthly and Special Distributions Declared in First Quarter 2020

On February 28, 2020, the Company's board of directors declared monthly distributions of $0.10 per share payable in each of April, May and June 2020 and a special distribution of $0.05 per share payable in April 2020.  The following table shows these monthly and special distributions, which total $0.35 per share:

Monthly Distributions

Special Distribution

After paying distributions of $1.10 per share deemed paid for tax purposes in 2019, declaring on October 25, 2019 a distribution of $0.10 per share payable January 15, 2020, and generating taxable earnings of $1.59 per share in 2019, the Company's undistributed spillover income as of December 31, 2019 was $0.42 per share. Spillover income includes any ordinary income and net capital gains from the preceding tax years that were not distributed during such tax years.

When declaring distributions, the Horizon board of directors reviews estimates of taxable income available for distribution, which may differ from consolidated net income under generally accepted accounting principles due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given year for distribution in the following year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.

Conference Call

The Company will host a conference call on Wednesday, March 4, 2020, at 9:00 a.m. ET to discuss its latest corporate developments and financial results. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (international). The access code for all callers is 13698376.  In addition, a live webcast will be available on the Company's website at www.horizontechfinance.com.

A replay of the call will be available through Friday, March 6, 2020 at (844) 512-2921 in the United States and (412) 317-6671 International, passcode 13698376. A webcast replay will be available on the Company's website for 30 days following the call.

About Horizon Technology Finance

Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Headquartered in Farmington, Connecticut, Horizon also has regional offices in Pleasanton, California and Reston, Virginia. To learn more, please visit www.horizontechfinance.com.

Forward-Looking Statements

Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts:

Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com 
(860) 284-6450

Media Relations:
ICR
Brian Ruby
brian.ruby@icrinc.com 
(203) 682-8268

 

 

 

 

View original content:http://www.prnewswire.com/news-releases/horizon-technology-finance-announces-fourth-quarter-and-full-year-2019-financial-results-301015677.html

SOURCE Horizon Technology Finance Corporation